2,468
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Mucosal co-delivery of ketorolac and lidocaine using polymeric wafers for dental application

, , & ORCID Icon
Pages 35-42 | Received 09 Oct 2017, Accepted 01 Dec 2017, Published online: 10 Dec 2017

References

  • Abd El-Hady A, Abd El-Rehim HA. (2004). Production of prednisolone by Pseudomonas oleovorans cells incorporated into PVP/PEO radiation cross-linked hydrogels. J Biomed Biotechnol 4:219–26.
  • Ayensua I, Mitchella JC, Boatenga JS. (2012). Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa. Colloids Surf B: Biointerfaces 91:258–65.
  • Betancourt JW, Kupp LI, Jasper SJ, Farooqi OW. (2004). Efficacy of ibuprofen-hydrocodone for the treatment of postoperative pain after periodontal surgery. J Periodontol 75:872–6.
  • Bhaskar SN, Frisch J, Margetis PM, Leonard F. (1966). Oral surgery-oral pathology conference No. 18, Walter Reed Army Medical Center. Application of a new chemical adhesive in periodontic and oral surgery. Oral Surg Oral Med Oral Pathol 22:526–35.
  • Boateng J, Catanzano O. (2015). Advanced therapeutic dressings for effective wound healing—a review. J Pharm Sci 104:3653–80.
  • Boateng JS, Auffret AD, Matthews KH, et al. (2010). Characterisation of lyophilised wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces. Int J Pharm 389:24–31.
  • Boateng JS, Matthews KH, Stevens HNE, Eccleston GM. (2008). Wound healing dressings and drug delivery systems: a review. J Pharm Sci 97: 2892–923.
  • Buckley MM, Brogden RN. (1990). Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 39:86–109.
  • Bunte H, Drooge DJ, Ottjes G, et al. (2010). Key considerations when developing freeze-dried formulation and current trends. Pharm Technol Eur Digit 22:2–4.
  • Carranza AC, Saglie FR. (1990). Clinical features of gingivitis. In: Glickman I, Carranza FA, eds. Glickman’s clinical periodontology. 7th ed. Philadelphia: Saunders, 109–25.
  • Catanzano O, Docking R, Schofield P, Boateng J. (2017). Advanced multi-targeted composite biomaterial dressing for pain and infection control in chronic leg ulcers. Carbohydr Polym 172:40–8.
  • DiPalma JR. (1991). Ketorolac: an injectable NSAID. Am Fam Phys 43:207–10.
  • Elsner JJ, Zilberman M. (2010). Novel antibiotic-eluting wound dressings: an in vitro study and engineering aspects in the dressing’s design. J Tissue Viabil 19:54–66.
  • Ernesto AL, Dent C. (2004). Aesthetic crown lengthening: classification, biologic rationale and treatment planning consideration. Pract Proced Aesthet Dent 16:769–78.
  • Fegade JD, Mehta HP, Chaudhari RY, Patil VR. (2009). Simultaneous spectrophotometric estimation of ofloxacin and ketorolac tromethamine in ophthalmic dosage form. Int J ChemTech Res 1:189–94.
  • Ghanbari H, Forouzanfar A, Fatemi K, et al. (2012). Modified Widman flap procedure: with or without periodontal dressing? OJST 2:170–2.
  • Gjerdet NR, Haugen E. (1977). Dimensional changes of periodontal dressings. J Dent Res 56:1507–10.
  • Grabovac V, Guggi D, Bernkop-Schnürch A. (2005). Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev 57:1713–23.
  • Hassan N, Ali M, Ali J. (2010). Development and evaluation of novel buccoadhesive wafers of nimodipine for treatment of hypertension. Drug Deliv 17:59–67.
  • Huang LH, Neiva RE, Soehren SE, et al. (2005). The effect of platelet-rich plasma on the coronally advanced flap root coverage procedure: a pilot human trial. J Periodontol 76:1768–77.
  • Jensen MP, Karoly P, Braver S. (1986). The measurement of clinical pain intensity: a comparison of six methods. Pain 27:117–26.
  • Kerr DA, Millard HD. (1969). Oral diagnosis. 2nd ed. C.V. St. Louis: Mosby Co., 17.
  • Lobo TM, Pol DG. (2015). Evaluation of the use of a 940 nm diode laser as an adjunct in flap surgery for treatment of chronic periodontitis. J Indian Soc Periodontol 19:43–8.
  • Martin P, Hopkinson-Wooley J, McClusky J. (1992). Growth factors and cutaneous wound repair. Prog Growth Factor Res 4:25–44.
  • Matthews KH, Stevens HNE, Auffret AD, et al. (2005). Lyophilised wafers as a drug delivery system for wound healing containing methylcellulose as a viscosity modifier. Int J Pharm 289:51–62.
  • Matthews KH, Stevens HNE, Auffret AD, et al. (2008). Formulation, stability and thermal analysis of lyophilised wound healing wafers containing an insoluble MMP-3 inhibitor and a non-ionic surfactant. Int J Pharm 356:110–20.
  • Matthews KH, Stevens HNE, Auffret AD, et al. (2003). Wafer for wounds. International Patent. Pfizer Ltd., WO 03,037,395, August 05.
  • Miranda LF, Lugao AB, Machado LDB, Ramanathan LV. (1999). Crosslinking and degradation of PVP hydrogels as a function of dose and PVP concentration. Rad Phys Chem 55:709–12.
  • Mohamad SA, Sarhan HA, Abdelkader H, Mansour HF. (2017). Vitamin B12e loaded buccoadhesive films as a non-invasive supplement in vitamin b12 deficiency: in vitro evaluation and in vivo comparative study with intramuscular injection. J Pharm Sci 106:1849–58.
  • Mortazavi SA, Smart J. (1993). An investigation into the role of water movement and mucus gel dehydration in mucoadhesion. J Control Release 25:197–203.
  • Ng SF, Jumaat N. (2014). Carboxymethyl cellulose wafers containing antimicrobials: a modern drug delivery system for wound infections. Eur J Pharm Sci 51:173–9.
  • Patel VM, Prajapati BG, Patel MM. (2007). Effect of hydrophilic polymerson buccoadhesive eudragit patches of propranolol hydrochloride using factorial design. AAPS PharmSciTech 8:E1–8.
  • Pawar HV, Boateng JS, Ayensu I, Tetteh J. (2014). Multifunctional medicated lyophilised wafer dressing for effective chronic wound healing. J Pharm Sci 103:1720–33.
  • Peh KK, Wong CF. (1999). Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci 2:53–61.
  • Pereira RA, Carvalho DC, Vaz MH, et al. (2013). Development of novel alginate based hydrogel films for wound healing applications. Int J Biol Macromol 52:221–30.
  • Pipa-Vallejo A, Garcia-Pola-Vallejo MJ. (2004). Local anesthetics in dentistry. Med Oral Patol Oral Cir Bucal 9:440–3.
  • Saarai A, Kasparkova V, Sedlacek T, et al. (2011). Comparative study of crosslinked sodium alginate/gelatin hydrogels for wound dressing. In: Mastorakis N, et al., eds. Recent researches in geography geology, energy, environment and biomedicine. Greece: WSEAS Press, 384–9.
  • Sachs HA, Farnosh A, Checchi L, Joseph CE. (1984). Current status of periodontal dressings. J Periodontol 55:689–96.
  • Salvi GE, Lang NP. (2005). The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. Curr Pharm Des 11:1757–69.
  • Skjåk-Braek G. (1992). Alginates: biosyntheses and some structure-function relationships relevant to biomedical and biotechnological applications. Biochem Soc Trans 20:27–33.
  • Thomas A, Harding KG, Moore K. (2000). Alginates from wound dressings activate human macrophages to secrete tumour necrosis factor-alpha. Biomaterials 21:1797–802.
  • Ward AW. (1929). Postoperative care in the surgical treatment of pyorrhea. JADA 16:635–40.
  • Wikesjö UM, Nilvéus RE, Selvig KA. (1992). Significance of early healing events on periodontal repair: a review. J Periodontol 63:158–65.
  • Wu ZM, Zhang XG, Zheng C, et al. (2009). Disulfide cross-linked chitosan hydrogel for cell viability and controlled protein release. Eur J Pharm Sci 37:198–206.
  • Zaki NM, Awad GA, Mortada ND, Abd ElHady SS. (2007). Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 32:296–307.